Jan-Niklas Eckardt

18PUBLICATIONS
59CO-AUTHORS
Medical biotechnology diagnostics (incl. biosensors)Modelling and simulationMedical mycologyPredictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Aug 26, 2026
Deep learning differentiates myeloproliferative neoplasms and predicts JAK2 and CALR mutations from bone marrow smears.

|Feb 20, 2026
Artificial intelligence-generated synthetic data for cancer research and clinical trials.

Jan-Niklas Eckardt, Waldemar Hahn, Arsela Prelaj

|Oct 28, 2025
Differential prognostic impact of myelodysplasia-related gene mutations in a European cohort of 4978 intensively treated AML patients.

Marius Bill, Jan-Niklas Eckardt, Konstanze Döhner

|Jul 28, 2025
Promises and challenges of artificial intelligence in haematological diagnostics.

Jan-Niklas Eckardt, Jan Moritz Middeke

|May 08, 2025
Age-stratified machine learning identifies divergent prognostic significance of molecular alterations in AML.

Jan-Niklas Eckardt, Waldemar Hahn, Rhonda E Ries

|Mar 05, 2025
The IKZF1 N159S mutation is associated with poor outcome and a distinct molecular profile in adult patients with AML.

Sebastian Stasik, Jan-Niklas Eckardt, Christoph Röllig

Pageof 3

Frequent Collaborators

10 joint publications

Sebastian Stasik

10 joint publications

Stefan W Krause

8 joint publications

Christoph Röllig

8 joint publications

Christian Thiede